Clinical-scale expansion of human cytomegalovirus-specific cytotoxic T lymphocytes from peripheral blood mononuclear cells requiring single-peptide stimulation and feeder cells but not additional antigen-presenting cells

Transfusion

Volumn 46, Issue 4, 2006, Pages 516-522

  Sakagawa, Hisako ^a   Azuma, Hiroshi ^a   Fujihara, Mitsuhiro ^a   Ikeda, Hisami ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 2; LYMPHOKINE; TETRAMER;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD DONOR; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; EX VIVO STUDY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOBLASTOID CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE SUBPOPULATION; LYMPHOKINE ACTIVATED KILLER CELL; MEMORY CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL;

ANTIGEN-PRESENTING CELLS; BLOOD DONORS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL SEPARATION; HUMANS; KINETICS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33645293742     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00773.x     Document Type: Article

References (16)

1. Zaia JA. Cytomegalovirus infection. In Thomas ED Blume KG Forman SJ editors. Hematopoietic cell transplantation. Malden (MA) Blackwell Science 1999. p. 5 60 83.
2. Prentice HG Gluckman E Powles RL et al. Impact of long-term acyclovir on cytomegalovirus infection and survival in allogeneic marrow transplantation. Lancet 1994 343 749 53.
3. Singhal S Mehta J Powles R et al. Three weeks of ganciclovir for cytomegaloviremia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995 15 777 81.
4. Walter EA Greenberg PD Gilbert MJ et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995 333 1038 44.
5. Riddele SR Watanabe KS Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992 257 238 41.
6. Sun Q Pollok KE Burton RL et al. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65. Blood 1999 94 3242 50.
7. Peggs K Verfuerth S Mackinnon S. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 2001 97 994 1000.
8. Carlsson B Cheng WS Totterman TH Essand M. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritc cells as stimulator. Br J Haematol 2003 121 428 38.
9. Papanicolaou GA Latouche JB Tan C et al. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Blood 2003 102 2498 505.
10. Szmania S Galloway A Bruorton M et al. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 2001 98 505 12.
11. Bissinger AL Rauser G Hebart H et al. Isolation and expansion of human cytomegalovirus-specific cytotoxic T lymphocytes using interferon-gamma secretion assay. Exp Hematol 2002 30 1178 84.
12. Provenzano M Mocellin S Bettinotti M et al. Identification of immune dominant coytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. J Immunother 2002 25 342 51.
13. Lichtenfels R Biddison WE Schulz H Vogt AB Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 1994 172 227 39.
14. Kataoka T Shinohara N Yakayama H et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996 156 3678 86.
15. Einsele H Roosnek E Rufer N et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002 99 3916 22.
16. Sallusto F Lenig D Forster R Lipp M Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 708 12.